SCHEMBL7813709

SCHEMBL7813709

CCc1nc2c(-c3ccc(Cl)cc3Cl)cccc2n1CC1(C2CC2)CC1

nearest known ligand 0.45

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 7/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7811659 0.90 LMNA (0.33)
SCHEMBL7819032 0.90 LMNA (0.35)
SCHEMBL7810862 0.80 CRHR1 (0.40) CRHR1
SCHEMBL7818929 0.76 PDCD1 (0.31) CRHR1
SCHEMBL7813707 0.75
SCHEMBL7814643 0.67 CRHR1 (0.42) CRHR1
SCHEMBL7816969 0.65 CCNT1 (0.40)
SCHEMBL7811654 0.64
SCHEMBL7819027 0.64
SCHEMBL3364024 0.63 CRHR1 (0.49) CRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1091941-A1 NOVEL BENZIMIDAZOLES AS CORTICOTROPIN RELEASE FACTOR ANTAGONISTS Du Pont Pharmaceuticals Company (US) 2001-04-18 EP claimed
WO-2000001675-A1 NOVEL BENZIMIDAZOLES AS CORTICOTROPIN RELEASE FACTOR ANTAGONISTS DU PONT PHARMACEUTICALS COMPANY (US) 2000-01-13 WO claimed
US-6124463-A TREATMENT OF AFFECTIVE DISORDER, ANXIETY OR DEPRESSION DUPONT PHARMACEUTICALS (US) 2000-09-26 US disclosed